- Sections
- A - Nécessités courantes de la vie
- A61K - Préparations à usage médical, dentaire ou pour la toilette
- A61K 31/33 - Composés hétérocycliques
Détention brevets de la classe A61K 31/33
Brevets de cette classe: 2926
Historique des publications depuis 10 ans
|
75
|
58
|
68
|
52
|
59
|
50
|
80
|
628
|
590
|
278
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Merck Sharp & Dohme LLC | 3741 |
46 |
| The Regents of the University of California | 19812 |
39 |
| University of Florida Research Foundation, Inc. | 3989 |
28 |
| Purdue Research Foundation | 3564 |
28 |
| The Board of Trustees of the Leland Stanford Junior University | 6365 |
21 |
| Praxis Precision Medicines, Inc. | 170 |
21 |
| The Johns Hopkins University | 5642 |
20 |
| The General Hospital Corporation | 4704 |
20 |
| The Trustees of Columbia University in the City of New York | 3558 |
20 |
| Amarin Pharmaceuticals Ireland Limited | 269 |
20 |
| Board of Regents, The University of Texas System | 5751 |
18 |
| Dana-Farber Cancer Institute, Inc. | 2553 |
17 |
| Emory University | 1619 |
16 |
| Caamtech, Inc. | 140 |
16 |
| The Scripps Research Institute | 1346 |
15 |
| Bristol-myers Squibb Company | 4892 |
14 |
| The Regents of the University of Michigan | 4670 |
14 |
| The Trustees of the University of Pennsylvania | 4308 |
14 |
| Yale University | 2358 |
14 |
| Kymera Therapeutics, Inc. | 225 |
14 |
| Autres propriétaires | 2511 |